Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults)
И. И. Дедов(Endocrinology Research Center), Valentin V. Fadeyev(Juvenile Diabetes Research Foundation), Л. А. Суплотова(Tyumen State Medical University), G. А. Melnichenko(Endocrinology Research Center), Natalia S. Bordan, Ekaterina А. Shestakova(Endocrinology Research Center), И. З. Бондаренко, Elena V. Biryukova, Л. Г. Стронгин, Н. А. Петунина, Marina V. Shestakova(Endocrinology Research Center), Fatima H. Dzgoeva, Е. А. Трошина(Endocrinology Research Center), Е. Г. Старостина, А. M. Mkrtumyan, Е. В. Ершова, А. Е. Неймарк(Federal Almazov North-West Medical Research Centre), Kseniya A. Komshilova, Н. В. Мазурина, Т. И. Романцова
Cited by 167
Related Papers
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
|The Lancet|2023|676
Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition
|Diabetes Mellitus|2019|257
The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)
|Diabetes Mellitus|2016|254
Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022
|Diabetes Mellitus|2023|248
Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th Edition
|Diabetes Mellitus|2023|206